Is there a reasonable excuse for not providing post-operative analgesia when using animal models of peripheral neuropathic pain for research purposes?
Open Access
- 22 November 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (11) , e0188113
Abstract
The induction of neuropathic pain-like behaviors in rodents often requires surgical intervention. This engages acute nociceptive signaling events that contribute to pain and stress post-operatively that from a welfare perspective demands peri-operative analgesic treatment. However, a large number of researchers avoid providing such care based largely on anecdotal opinions that it might interfere with model pathophysiology in the longer term. To investigate effects of various peri-operative analgesic regimens encapsulating different mechanisms and duration of action, on the development of post-operative stress/welfare and pain-like behaviors in the Spared Nerve Injury (SNI)-model of neuropathic pain. Starting on the day of surgery, male Sprague-Dawley rats were administered either vehicle (s.c.), carprofen (5.0mg/kg, s.c.), buprenorphine (0.1mg/kg s.c. or 1.0mg/kg p.o. in Nutella®), lidocaine/bupivacaine mixture (local irrigation) or a combination of all analgesics, with coverage from a single administration, and up to 72 hours. Post-operative stress and recovery were assessed using welfare parameters, bodyweight, food-consumption, and fecal corticosterone, and hindpaw mechanical allodynia was tested for assessing development of neuropathic pain for 28 days. None of the analgesic regimes compromised the development of mechanical allodynia. Unexpectedly, the combined treatment with 0.1mg/kg s.c. buprenorphine and carprofen for 72 hours and local irrigation with lidocaine/bupivacaine, caused severe adverse effects with peritonitis. This was not observed when the combination included a lower dose of buprenorphine (0.05mg/kg, s.c.), or when buprenorphine was administered alone (0.1mg/kg s.c. or 1.0mg/kg p.o.) for 72 hours. An elevated rate of wound dehiscence was observed especially in the combined treatment groups, underlining the need for balanced analgesia. Repeated buprenorphine injections had positive effects on body weight the first day after surgery, but depressive effects on food intake and body weight later during the first week. Post-operative analgesia does not appear to affect established neuropathic hypersensitivity outcome in the SNI model.Keywords
This publication has 53 references indexed in Scilit:
- Deconstructing the Neuropathic Pain Phenotype to Reveal Neural MechanismsNeuron, 2012
- Preventive analgesiaCurrent Opinion in Anaesthesiology, 2011
- Perioperative Nerve Blockade: Clues from the BenchAnesthesiology Research and Practice, 2011
- Reported analgesic and anaesthetic administration to rodents undergoing experimental surgical proceduresLaboratory Animals, 2009
- Neuropathic PainPharmacoEconomics, 2009
- Quantification of stress sensitive markers in single fecal samples do not accurately predict excretion of these in the pigResearch in Veterinary Science, 2007
- Comparative actions of the opioid analgesics morphine, methadone and codeine in rat models of peripheral and central neuropathic painPain, 2005
- Buprenorphine reduces central sensitization after repetitive C-fiber stimulation in ratsNeuroscience Letters, 2004
- Options for management of acute pain in the ratVeterinary Record, 1997
- General class of covariance structures for two or more repeated factors in longitudinal data analysisCommunications in Statistics - Theory and Methods, 1994